US Stock MarketDetailed Quotes
ALZN Alzamend Neuro
- 1.3000
- -0.0100-0.76%
Close Nov 21 16:00 ET
- 1.3000
- 0.00000.00%
Post 20:01 ET
5.82MMarket Cap-122P/E (TTM)
1.3200High1.2700Low139.58KVolume1.2900Open1.3100Pre Close181.45KTurnover3.21%Turnover RatioLossP/E (Static)4.48MShares15.060052wk High-4.80P/B5.65MFloat Cap1.250052wk Low--Dividend TTM4.35MShs Float5032.5000Historical High--Div YieldTTM3.82%Amplitude1.2500Historical Low1.2990Avg Price1Lot Size
Alzamend Neuro Key Stats
Quarterly+Annual
YOY
| (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -29.58%1.19M | -92.69%376.05K | -92.69%376.05K | -96.16%282.87K | -97.82%200.08K | -85.29%1.7M | -63.45%5.14M | -63.45%5.14M | -37.44%7.38M | -32.34%9.18M |
| -Cash and cash equivalents | -29.58%1.19M | -92.69%376.05K | -92.69%376.05K | -96.16%282.87K | -97.82%200.08K | -85.29%1.7M | -63.45%5.14M | -63.45%5.14M | -37.44%7.38M | -32.34%9.18M |
| Prepaid assets | -69.06%222.24K | -88.60%79.19K | -88.60%79.19K | -70.15%310.74K | -49.48%581.8K | 24.23%718.19K | 98.71%694.92K | 98.71%694.92K | 62.95%1.04M | 26.27%1.15M |
| Total current assets | -41.32%1.42M | -92.20%455.24K | -92.20%455.24K | -92.95%593.61K | -92.43%781.88K | -80.08%2.41M | -59.51%5.84M | -59.51%5.84M | -32.28%8.42M | -28.73%10.33M |
| Non current assets | ||||||||||
| Net PPE | 18.31%253.66K | 120.87%176.35K | 120.87%176.35K | 121.96%189.03K | 122.92%201.72K | 123.77%214.4K | -22.41%79.84K | -22.41%79.84K | --85.17K | --90.49K |
| Total non current assets | 18.31%253.66K | 120.87%176.35K | 120.87%176.35K | 121.96%189.03K | 122.92%201.72K | 123.77%214.4K | -22.41%79.84K | -22.41%79.84K | --85.17K | --90.49K |
| Total assets | -36.46%1.67M | -89.32%631.59K | -89.32%631.59K | -90.79%782.64K | -90.56%983.6K | -78.48%2.63M | -59.25%5.92M | -59.25%5.92M | -31.60%8.5M | -28.11%10.42M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | ---- | 1.91%2.93M | 1.91%2.93M | ---- | ---- | 166.44%2.74M | 146.38%2.87M | 146.38%2.87M | 465.87%2.64M | 44.83%1.64M |
| -accounts payable | ---- | 1.91%2.93M | 1.91%2.93M | ---- | ---- | 166.44%2.74M | 146.82%2.87M | 146.82%2.87M | 468.40%2.64M | -42.56%648.12K |
| -Due to related parties current | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 45,240.70%989.33K |
| Current debt and capital lease obligation | ---- | --300.71K | --300.71K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current debt | ---- | --300.71K | --300.71K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current liabilities | 5.15%2.88M | 12.39%3.23M | 12.39%3.23M | 44.81%3.83M | 123.89%3.67M | 166.44%2.74M | 146.38%2.87M | 146.38%2.87M | 465.87%2.64M | 10.98%1.64M |
| Non current liabilities | ||||||||||
| Derivative product liabilities | ---- | ---- | ---- | --742.26K | ---- | ---- | ---- | ---- | ---- | ---- |
| Preferred securities outside stock equity | ---- | ---- | ---- | --477.74K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | --0 | --0 | --0 | --1.22M | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 5.15%2.88M | 12.39%3.23M | 12.39%3.23M | 90.97%5.05M | 123.89%3.67M | 166.44%2.74M | 146.38%2.87M | 146.38%2.87M | 465.87%2.64M | 10.98%1.64M |
| Shareholders'equity | ||||||||||
| Share capital | -99.11%86 | 6.15%69 | 6.15%69 | -93.13%662 | -93.22%647 | 1.53%9.69K | -99.32%65 | -99.32%65 | 7.01%9.64K | 7.47%9.55K |
| -common stock | -99.11%86 | 6.15%69 | 6.15%69 | -93.13%662 | -93.22%647 | 1.53%9.69K | -99.32%65 | -99.32%65 | 7.01%9.64K | 7.47%9.55K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -15.53%-54.99M | -22.57%-54.02M | -22.57%-54.02M | -30.42%-53.17M | -42.91%-50.51M | -47.68%-47.6M | -50.96%-44.07M | -50.96%-44.07M | -60.98%-40.77M | -55.33%-35.34M |
| Paid-in capital | -13.76%53.78M | -17.06%51.43M | -17.06%51.43M | -20.37%48.97M | 6.27%62.7M | 6.99%62.36M | 7.98%62M | 7.98%62M | 17.90%61.5M | 16.49%59M |
| Other equity interest | ---- | ---- | ---- | 99.53%-70K | 0.05%-14.88M | 0.00%-14.88M | 0.00%-14.88M | 0.00%-14.88M | 0.00%-14.88M | 0.00%-14.88M |
| Total stockholders'equity | -973.96%-1.21M | -185.18%-2.59M | -185.18%-2.59M | -172.77%-4.26M | -130.53%-2.68M | -101.01%-112.88K | -77.19%3.05M | -77.19%3.05M | -51.02%5.86M | -32.54%8.79M |
| Total equity | -973.96%-1.21M | -185.18%-2.59M | -185.18%-2.59M | -172.77%-4.26M | -130.53%-2.68M | -101.01%-112.88K | -77.19%3.05M | -77.19%3.05M | -51.02%5.86M | -32.54%8.79M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data